TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: The Effect on Gait and Activity Level of a Physiotherapy Intervention Aimed at Improving Mediolateral Stability 4 Months After a Hip Fracture
Brief Summary: To evaluate the effect on gait and activity of a home based physiotherapy intervention 4-6 months after the fracture. The investigators hypothesis is that exercises performed after the initial rehabilitation, which focuses on specific components of gait control will improve gait and increase level of activity.


Options:
A: Arm Label: Rehabilitation without strength training; Type: ACTIVE_COMPARATOR; Interventions: Other: Rehabilitation without strength training | Arm Label: Rehabilitation with strength training; Type: EXPERIMENTAL; Interventions: Other: Rehabilitation with strength training | Intervention Type: OTHER; Name: Rehabilitation with strength training; Assigned to Arm(s): Rehabilitation with strength training | Intervention Type: OTHER; Name: Rehabilitation without strength training; Assigned to Arm(s): Rehabilitation without strength training
B: Arm Label: Functional training group; Type: EXPERIMENTAL; Interventions: Other: Functional training program | Arm Label: Control group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Functional training program; Assigned to Arm(s): Functional training group
C: Arm Label: Conventional rehabilitation; Type: ACTIVE_COMPARATOR; Interventions: Other: Conventional rehabilitation | Arm Label: Aerobic exercise; Type: ACTIVE_COMPARATOR; Interventions: Other: Conventional rehabilitation, Other: Aerobic exercise | Intervention Type: OTHER; Name: Conventional rehabilitation; Assigned to Arm(s): Aerobic exercise, Conventional rehabilitation | Intervention Type: OTHER; Name: Aerobic exercise; Assigned to Arm(s): Aerobic exercise
D: Arm Label: physiotherapy; Type: EXPERIMENTAL; Interventions: Procedure: physiotherapy | Arm Label: conventional treatment; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: PROCEDURE; Name: physiotherapy; Assigned to Arm(s): physiotherapy

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Childhood Immunization: Reducing Immunization Distress (RID) Using Multi-Modal Distraction
Brief Summary: The purpose of this study is to compare the effectiveness of a more feasible method for reducing the pain and distress of childhood immunization with the standard method in use at the Pediatric Medical Group. A secondary aim is to evaluate the impact of parental involvement on the parent and child satisfaction with the immunization experience.

Study Hypotheses: In the standard, pre-kindergarten, two- or three vaccine sequence, there will be no statistically significant group differences between PPT and ST with respect to:

1. Child self-reported pain using the Faces Pain Scale-Revised (FPS-R) scale13 (primary outcome);
2. Parent report of child pain using the FPS-R;
3. Observer-rated child distress and pain using the Face, Legs, Activity, Cry, and Consolability (FLACC) scale14;
4. Parent and child satisfaction with pain management during immunization measured by a 5-point Likert type scales;
5. Time required for completion of immunization from initiation of ST or PPT to 2 minutes after completion of the last injection.


Options:
A: Arm Label: Standard technique; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Standard technique | Arm Label: Parent participation technique; Type: EXPERIMENTAL; Interventions: Behavioral: Parent participation technique | Intervention Type: BEHAVIORAL; Name: Standard technique; Assigned to Arm(s): Standard technique | Intervention Type: BEHAVIORAL; Name: Parent participation technique; Assigned to Arm(s): Parent participation technique
B: Arm Label: Standard Care; Type: OTHER; Interventions: Other: vapocoolant | Arm Label: Buzzy; Type: EXPERIMENTAL; Interventions: Device: Buzzy | Intervention Type: DEVICE; Name: Buzzy; Assigned to Arm(s): Buzzy | Intervention Type: OTHER; Name: vapocoolant; Assigned to Arm(s): Standard Care
C: Arm Label: Conventional syringe; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Camouflage syringe; Type: EXPERIMENTAL; Interventions: Procedure: Camouflage syringe | Intervention Type: PROCEDURE; Name: Camouflage syringe; Assigned to Arm(s): Camouflage syringe
D: Arm Label: music; Type: EXPERIMENTAL; Interventions: Behavioral: music | Arm Label: Standard care; Type: OTHER; Interventions: Behavioral: music | Intervention Type: BEHAVIORAL; Name: music; Assigned to Arm(s): Standard care, music

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Randomized Controlled Study of Extracorporeal Photopheresis (ECP) Therapy With UVADEX for the Treatment of Patients With Moderate to Severe Chronic Graft-versus-Host Disease (cGvHD)
Brief Summary: Chronic graft-versus-host disease (cGVHD) is a long-lasting complication that can occur after transplants. The transplanted cells seem to fight with the patient's own cells.

Extracorporeal photopheresis (ECP) is a fairly new procedure for cGVHD. The participant gets a port to hook up to a machine. The machine removes the white blood cells, mixes them with a light-sensitive drug, shines light on it, and puts all the blood back in.

This study will find out if patients respond better if they get ECP with methoxsalen, in addition to the pills normally used to treat cGVHD.


Options:
A: Arm Label: Mycophenolate mofetil; Type: ACTIVE_COMPARATOR; Interventions: Drug: mycophenolate mofetil | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: placebo | Intervention Type: DRUG; Name: mycophenolate mofetil; Assigned to Arm(s): Mycophenolate mofetil | Intervention Type: DRUG; Name: placebo; Assigned to Arm(s): Placebo
B: Arm Label: ECP Methoxsalen + Standard of Care; Type: EXPERIMENTAL; Interventions: Drug: ECP Methoxsalen, Drug: Standard of Care | Arm Label: Standard of Care; Type: ACTIVE_COMPARATOR; Interventions: Drug: Standard of Care | Intervention Type: DRUG; Name: ECP Methoxsalen; Assigned to Arm(s): ECP Methoxsalen + Standard of Care | Intervention Type: DRUG; Name: Standard of Care; Assigned to Arm(s): ECP Methoxsalen + Standard of Care, Standard of Care
C: N/A
D: Intervention Type: DRUG; Name: Pentostatin; Assigned to Arm(s): N/A

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Immunogenicity and Safety Study of GlaxoSmithKline Biologicals' HPV-16/18 L1 AS04 Vaccine When Administered According to Alternative 2-dose Schedules in 9 - 14 Year Old Females
Brief Summary: This study has been designed to evaluate the immunogenicity and safety of GSK Biologicals' HPV-16/18 vaccine when administered according to alternative 2-dose schedules (0,6 months and 0,12 months) in healthy 9-14 year old females as compared to the standard 3-dose schedule (0,1,6 months) in 15-25 year old females.


Options:
A: Arm Label: Cervarix 1/Placebo Group; Type: EXPERIMENTAL; Interventions: Biological: Cervarix, Drug: Placebo | Arm Label: Cervarix 1/Placebo/Cervarix 1 Group; Type: EXPERIMENTAL; Interventions: Biological: Cervarix, Drug: Placebo | Arm Label: Cervarix 2/Placebo/Cervarix 2 Group; Type: EXPERIMENTAL; Interventions: Biological: Cervarix, Drug: Placebo | Arm Label: Cervarix 2 Group; Type: EXPERIMENTAL; Interventions: Biological: Cervarix | Intervention Type: BIOLOGICAL; Name: Cervarix; Assigned to Arm(s): Cervarix 1/Placebo Group, Cervarix 1/Placebo/Cervarix 1 Group, Cervarix 2 Group, Cervarix 2/Placebo/Cervarix 2 Group | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Cervarix 1/Placebo Group, Cervarix 1/Placebo/Cervarix 1 Group, Cervarix 2/Placebo/Cervarix 2 Group
B: Arm Label: HIV+/Cervarix Group; Type: EXPERIMENTAL; Interventions: Biological: Cervarix | Arm Label: HIV+/Aluminium Hydroxide Group; Type: ACTIVE_COMPARATOR; Interventions: Biological: Placebo Control | Arm Label: HIV-/Cervarix Group; Type: EXPERIMENTAL; Interventions: Biological: Cervarix | Intervention Type: BIOLOGICAL; Name: Cervarix; Assigned to Arm(s): HIV+/Cervarix Group, HIV-/Cervarix Group | Intervention Type: BIOLOGICAL; Name: Placebo Control; Assigned to Arm(s): HIV+/Aluminium Hydroxide Group
C: Arm Label: Cervarix 1 Group; Type: EXPERIMENTAL; Interventions: Biological: GSK Biologicals' HPV vaccine 580299 | Arm Label: Cervarix 2 Group; Type: ACTIVE_COMPARATOR; Interventions: Biological: GSK Biologicals' HPV vaccine 580299 | Arm Label: Cervarix 3 Group; Type: EXPERIMENTAL; Interventions: Biological: GSK Biologicals' HPV vaccine 580299 | Intervention Type: BIOLOGICAL; Name: GSK Biologicals' HPV vaccine 580299; Assigned to Arm(s): Cervarix 1 Group, Cervarix 2 Group, Cervarix 3 Group
D: Arm Label: no HPV vaccine; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: HPV vaccine (Cervarix®, GlaxoSmithKline); Type: EXPERIMENTAL; Interventions: Biological: Cervarix®, GlaxoSmithKline | Intervention Type: BIOLOGICAL; Name: Cervarix®, GlaxoSmithKline; Assigned to Arm(s): HPV vaccine (Cervarix®, GlaxoSmithKline)

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Immunogenicity and Safety Study of GlaxoSmithKline Biologicals' HPV-16/18 L1 AS04 Vaccine When Administered According to Alternative 2-dose Schedules in 9 - 14 Year Old Females
Brief Summary: This study has been designed to evaluate the immunogenicity and safety of GSK Biologicals' HPV-16/18 vaccine when administered according to alternative 2-dose schedules (0,6 months and 0,12 months) in healthy 9-14 year old females as compared to the standard 3-dose schedule (0,1,6 months) in 15-25 year old females.


Options:
A: Arm Label: Cervarix Group; Type: EXPERIMENTAL; Interventions: Biological: HPV-16/18 L1 VLP AS04 (Cervarix TM) | Arm Label: Placebo Group; Type: PLACEBO_COMPARATOR; Interventions: Biological: Placebo | Intervention Type: BIOLOGICAL; Name: Placebo; Assigned to Arm(s): Placebo Group | Intervention Type: BIOLOGICAL; Name: HPV-16/18 L1 VLP AS04 (Cervarix TM); Assigned to Arm(s): Cervarix Group
B: Intervention Type: BIOLOGICAL; Name: HPV 16/18 VLP AS04; Assigned to Arm(s): N/A
C: Arm Label: Cervarix Group; Type: EXPERIMENTAL; Interventions: Biological: HPV GSK 580299 vaccine | Arm Label: Placebo Group; Type: PLACEBO_COMPARATOR; Interventions: Biological: Placebo control | Intervention Type: BIOLOGICAL; Name: HPV GSK 580299 vaccine; Assigned to Arm(s): Cervarix Group | Intervention Type: BIOLOGICAL; Name: Placebo control; Assigned to Arm(s): Placebo Group
D: Arm Label: Cervarix 1 Group; Type: EXPERIMENTAL; Interventions: Biological: GSK Biologicals' HPV vaccine 580299 | Arm Label: Cervarix 2 Group; Type: ACTIVE_COMPARATOR; Interventions: Biological: GSK Biologicals' HPV vaccine 580299 | Arm Label: Cervarix 3 Group; Type: EXPERIMENTAL; Interventions: Biological: GSK Biologicals' HPV vaccine 580299 | Intervention Type: BIOLOGICAL; Name: GSK Biologicals' HPV vaccine 580299; Assigned to Arm(s): Cervarix 1 Group, Cervarix 2 Group, Cervarix 3 Group

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Double-Blind, Placebo-Controlled, Randomized, Crossover, Multicenter Study to Evaluate the Effect of JNJ-28431754 (Canagliflozin) on Post-Meal Glucose in Subjects With Type 2 Diabetes Mellitus
Brief Summary: The purpose of this study is to evaluate the effect of canagliflozin on post-meal glucose blood levels in patients with Type 2 Diabetes Mellitus.


Options:
A: Arm Label: BI 1356; Type: EXPERIMENTAL; Interventions: Drug: BI 1356 | Arm Label: placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: placebo | Intervention Type: DRUG; Name: BI 1356; Assigned to Arm(s): BI 1356 | Intervention Type: DRUG; Name: placebo; Assigned to Arm(s): placebo
B: Arm Label: 001; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Arm Label: 002; Type: EXPERIMENTAL; Interventions: Drug: Canagliflozin 300mg/Placebo | Arm Label: 003; Type: EXPERIMENTAL; Interventions: Drug: Canagliflozin 300mg | Arm Label: 004; Type: EXPERIMENTAL; Interventions: Drug: Canagliflozin 300mg/Canagliflozin 150mg | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): 001 | Intervention Type: DRUG; Name: Canagliflozin 300mg/Placebo; Assigned to Arm(s): 002 | Intervention Type: DRUG; Name: Canagliflozin 300mg/Canagliflozin 150mg; Assigned to Arm(s): 004 | Intervention Type: DRUG; Name: Canagliflozin 300mg; Assigned to Arm(s): 003
C: Arm Label: Sitagliptin; Type: EXPERIMENTAL; Interventions: Drug: Sitagliptin | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Sitagliptin; Assigned to Arm(s): Sitagliptin | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
D: Arm Label: Intensified insulin treatment; Type: EXPERIMENTAL; Interventions: Drug: Intensified insulin treatment | Arm Label: Standard treatment; Type: ACTIVE_COMPARATOR; Interventions: Drug: Standard treatment | Arm Label: Healthy controls; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DRUG; Name: Intensified insulin treatment; Assigned to Arm(s): Intensified insulin treatment | Intervention Type: DRUG; Name: Standard treatment; Assigned to Arm(s): Standard treatment

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Evaluation of AlcoholEdu: A Randomized Multi-Campus Trial
Brief Summary: The study examined whether an online course for college freshmen (AlcoholEdu) had an effect on alcohol misuse and related problems, using a randomized controlled design with 30 universities.


Options:
A: Arm Label: Alcohol education and prevention; Type: EXPERIMENTAL; Interventions: Behavioral: AlcoholEdu for College | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: AlcoholEdu for College; Assigned to Arm(s): Alcohol education and prevention
B: Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Adapted Motivational Interviewing & Skills Training | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Adapted Motivational Interviewing & Skills Training | Arm Label: 3; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Adapted Motivational Interviewing & Skills Training; Assigned to Arm(s): 1, 2
C: Intervention Type: PROCEDURE; Name: Internet personalized alcohol feedback (PAF); Assigned to Arm(s): N/A
D: Arm Label: Monitoring Alone; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Monitoring plus contingency management for abstinence; Type: EXPERIMENTAL; Interventions: Behavioral: contingency management for abstinence | Intervention Type: BEHAVIORAL; Name: contingency management for abstinence; Assigned to Arm(s): Monitoring plus contingency management for abstinence

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: The Efficacy of Pulsed Electromagnetic Field Therapy for Management of Post-operative Pain Following Cesarean Delivery: a Randomised, Double-blind, Placebo-controlled Study
Brief Summary: Pain following Cesarean delivery remains the most common post-operative complaint, and the provision of effective and safe analgesia is very important. Pain can impede the mother's ability to mobilise, and to care for and breastfeed her newborn baby.

Pulsed electromagnetic field (PEMF) devices have been used in various clinical settings, especially after plastic surgeries, to reduce postoperative swelling and pain, as well as to accelerate wound repair. PEMF therapy is simple to use, cost-effective and has no known side effects.

Despite advances in post-operative analgesia, pain relief and maternal satisfaction remain inadequate in some patients. Improving the quality of post-Cesarean analgesia while limiting undesirable side effects will enhance maternal satisfaction and reduce the risk of post-operative complications.

The investigators hypothesize that the continuous use of a PEMF device for 48 hours after Cesarean delivery will result in decreased post-operative pain scores on movement at 48 hours.


Options:
A: Arm Label: SofPulse nonfunctional device.; Type: PLACEBO_COMPARATOR; Interventions: Device: SofPulse | Arm Label: Active; Type: ACTIVE_COMPARATOR; Interventions: Device: SofPulse | Intervention Type: DEVICE; Name: SofPulse; Assigned to Arm(s): Active, SofPulse nonfunctional device.
B: Arm Label: Standard of Care; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Battlefield Auricular Acupuncture; Type: EXPERIMENTAL; Interventions: Device: Battlefield Auricular Acupuncture | Intervention Type: DEVICE; Name: Battlefield Auricular Acupuncture; Assigned to Arm(s): Battlefield Auricular Acupuncture
C: Arm Label: Active device; Type: ACTIVE_COMPARATOR; Interventions: Device: Pulsed electromagnetic field device (ActiPatch TM) | Arm Label: Placebo - inactive device; Type: PLACEBO_COMPARATOR; Interventions: Device: Inactive pulsed electromagnetic field device (ActiPatch TM) | Intervention Type: DEVICE; Name: Pulsed electromagnetic field device (ActiPatch TM); Assigned to Arm(s): Active device | Intervention Type: DEVICE; Name: Inactive pulsed electromagnetic field device (ActiPatch TM); Assigned to Arm(s): Placebo - inactive device
D: Arm Label: grupo TENS com frequência de 100 Hz; Type: EXPERIMENTAL; Interventions: Device: transcutaneous electrical nerve stimulation | Arm Label: grupo TENS com frequência de 4 Hz; Type: EXPERIMENTAL; Interventions: Device: transcutaneous electrical nerve stimulation | Arm Label: Placebo with TENS off; Type: PLACEBO_COMPARATOR; Interventions: Device: transcutaneous electrical nerve stimulation | Intervention Type: DEVICE; Name: transcutaneous electrical nerve stimulation; Assigned to Arm(s): Placebo with TENS off, grupo TENS com frequência de 100 Hz, grupo TENS com frequência de 4 Hz

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Nuevo Amanecer: Promoting the Psychosocial Health of Latinas
Brief Summary: The purpose of this study is to test whether a new program Nuevo Amanecer (A New Dawn), improves the quality of life of Latinas diagnosed with breast cancer. Trained Latina counselors who have had breast cancer provide support to recently diagnosed women. The investigators call these counselors peer support counselors.


Options:
A: Arm Label: Cognitive therapy of depression; Type: EXPERIMENTAL; Interventions: Behavioral: Cognitive therapy of depression | Arm Label: Bright light therapy; Type: EXPERIMENTAL; Interventions: Behavioral: Bright light therapy | Arm Label: Waiting list; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Cognitive therapy of depression; Assigned to Arm(s): Cognitive therapy of depression | Intervention Type: BEHAVIORAL; Name: Bright light therapy; Assigned to Arm(s): Bright light therapy
B: Arm Label: Cognitive-behavioral therapy and hypnosis group; Type: EXPERIMENTAL; Interventions: Behavioral: Cognitive-behavioral therapy and hypnosis group | Arm Label: Support group; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Support group | Intervention Type: BEHAVIORAL; Name: Cognitive-behavioral therapy and hypnosis group; Assigned to Arm(s): Cognitive-behavioral therapy and hypnosis group | Intervention Type: BEHAVIORAL; Name: Support group; Assigned to Arm(s): Support group
C: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Behavioral: Mindfulness-Based Stress Reduction | Arm Label: 2; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Mindfulness-Based Stress Reduction; Assigned to Arm(s): 1
D: Arm Label: Peer Support Program; Type: EXPERIMENTAL; Interventions: Behavioral: Peer Support Program | Arm Label: Wait-list Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Peer Support Program; Assigned to Arm(s): Peer Support Program

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Randomized Controlled Trial (RCT) to Compare Adenoma Detection Rate of Combined Chromoendoscopy (Indigo Carmine) With Water Infusion in Lieu of Air Insufflation (Water Method) vs. Water Method Alone in Screening Colonoscopy
Brief Summary: In a RCT in screening colonoscopy subjects, we will determine if chromoendoscopy using a dilute solution of Indigocarmine (IC) delivered by the water method (study method) will improve adenoma detection rate compared with the water method with plain water alone (control method).


Options:
A: Arm Label: colonoscopy; Type: EXPERIMENTAL; Interventions: Device: Olympus NBI colonoscope 180 HDTV narrow band imaging (diagnostic test) | Intervention Type: DEVICE; Name: Olympus NBI colonoscope 180 HDTV narrow band imaging (diagnostic test); Assigned to Arm(s): colonoscopy
B: Arm Label: Group A - COLO, then TER; Type: EXPERIMENTAL; Interventions: Device: Third Eye Retroscope | Arm Label: Group B - TER, then COLO; Type: ACTIVE_COMPARATOR; Interventions: Device: Third Eye Retroscope | Intervention Type: DEVICE; Name: Third Eye Retroscope; Assigned to Arm(s): Group A - COLO, then TER, Group B - TER, then COLO
C: Intervention Type: DRUG; Name: Esomeprazole; Assigned to Arm(s): N/A
D: Arm Label: Water method and chromoendoscopy; Type: EXPERIMENTAL; Interventions: Procedure: Water method and chromoendoscopy | Arm Label: Water method; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Water method | Intervention Type: PROCEDURE; Name: Water method and chromoendoscopy; Assigned to Arm(s): Water method and chromoendoscopy | Intervention Type: PROCEDURE; Name: Water method; Assigned to Arm(s): Water method

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Impact of Crew Resource Management Training to Improve the Effectiveness of Surgical Safety Checklist
Brief Summary: This multicenter cluster-randomized trial will evaluate the impact of Crew Resource Management training on the occurrence of postoperative complications and the adherence to a surgical safety checklist, among a large sample of French surgical departments.


Options:
A: Intervention Type: BEHAVIORAL; Name: HIP: HIV Intervention for Providers; Assigned to Arm(s): N/A
B: Arm Label: Control; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Control | Arm Label: HW; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: HW | Arm Label: HWC; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: HWC | Intervention Type: BEHAVIORAL; Name: Control; Assigned to Arm(s): Control | Intervention Type: BEHAVIORAL; Name: HW; Assigned to Arm(s): HW | Intervention Type: BEHAVIORAL; Name: HWC; Assigned to Arm(s): HWC
C: Arm Label: CRM training of surgical teams; Type: N/A; Interventions: Other: Diffusion of a surgical safety checklist | Arm Label: No CRM training of surgical teams; Type: N/A; Interventions: N/A | Intervention Type: OTHER; Name: Diffusion of a surgical safety checklist; Assigned to Arm(s): CRM training of surgical teams
D: Arm Label: Implementation intervention; Type: EXPERIMENTAL; Interventions: Other: Implementation intervention | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Implementation intervention; Assigned to Arm(s): Implementation intervention

Answer: C